| |
|
|
|
Acasti Pharma Inc.  
|
|
0.56 0 (0%) |
07-20 15:55 |
|
Open: |
0.55 |
Pre close: |
0.56 |
Target:
|
0.81 
|
|
High: |
0.5654 |
Low: |
0.55 |
Resistance:
|
0.69
0.79
|
|
Volume: |
64,257 |
Market Cap: |
20M |
Support:
|
0.53
0.44
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.56
|
MACD |
MACD(12,26):
|
-0.03  |
|
MA(20): |
0.60 |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
0.81 |
Stochastic Oscillator |
%K(14,3):
|
18.64 |
|
MA(250): |
1.09 |
%D(3): |
14.95 |
|
Average Volume(K) |
3-Month: |
22690
|
52-Week |
High:
|
3.36 |
|
10-Days: |
13622 |
Low: |
0.53 |
|
RSI |
RSI(14):
|
37.53 |
Change(%): |
-57.6 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-143.7 |
Shares Out. (M) |
36.17 |
|
EPS Est. Current Year |
-0.730 |
Return on Assets (ttm) |
-88.8 |
Shares Float (M) |
36.17 |
|
EPS Est. Next Year |
-0.770 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
1.70 |
|
Forward EPS |
-0.351 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
369 |
|
Book Value (p.s.) |
3.520 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.16 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-9.41 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-4.20 |
P/CF |
-2.15 |
|
|
|
|
|
|
